IntuitiveX

Website Contact the business

IntuitiveX IntuitiveX is an AI-first medical incubator and consultancy that specializes in medical startups

With a team comprised of life science entrepreneurs, investors, and innovators, we bring a combined 100+ years of experience in R&D, Clinical, Surgical, IP Strategy, Prototyping, Product Development, and Commercialization. We catalyze medical innovation by removing the complexities, cost barriers, and time sensitivities related to introducing new products into the market. From initial concept to final commercialization, IntuitiveX has the in-house knowledge and network to meet the unique needs of the most innovative life science companies in the world. We’ve currently incubated more than 12+ portfolio companies and are always in search of more.

You’ve invested in your idea. What happens when someone challenges it or copies it?Join IntuitiveX at North American Spi...
10/06/2026

You’ve invested in your idea. What happens when someone challenges it or copies it?

Join IntuitiveX at North American Spine Society (NASS) 2026 for “Defending Your IP in the Real World,” a conversation about protecting innovation and navigating IP challenges.

Hear perspectives from patent and legal professionals on protecting what you’re building, responding to threats, and avoiding costly missteps. Explore how IP decisions can affect your company as it grows and what to consider before a dispute arises.

Meet the panel:

Andrea Davis, MSc, QPIP - Founder and patent research expert at Bodkin IP, LLC
Karl Klassen, JD - Patent Attorney at Ashurst Perkins Coie
Josh Budwin, JD - Founding Shareholder at Budwin Kamprath Burgess Campbell PLLC

Moderated by Jeffrey Roh, MD, MBA, MSc. - Chief Executive Officer at IntuitiveX

Whether you’re developing your first invention or building a company around it, bring your questions.

IntuitiveX is proud to be the Title Sponsor of Spine Venture Village at NASS 2026.

Wednesday, October 14, 2026 | 10:00–11:00 AM CDT
Spine Venture Village, Booth #1405 | Henry B. Gonzalez Convention Center

How do you know when a clinical problem is worth building a company around and what does it take to move that idea forwa...
10/05/2026

How do you know when a clinical problem is worth building a company around and what does it take to move that idea forward?

Join IntuitiveX at North American Spine Society (NASS) 2026 for “Startup Innovation in Spine,” a conversation with physicians working at the intersection of clinical practice, research and entrepreneurship.

Explore where startup ideas begin, how new technology is changing surgical training and what it takes to bring an innovation out of a university lab and into a company. Hear perspectives on the journey from identifying a clinical need to developing a solution, including a look at technology for training surgeons in endoscopic spine surgery.

Meet the panel:

Jeffrey Roh, MD, MBA, MSc - CEO at IntuitiveX
Bernardo Drummond, MD, PhD - Minimally Spine Spine Surgeon at Alberte Einstein Israelite Hospital
Tom Noh, MD - Neurosurgeon and Chief Business and Strategy Officer at Excel Health

Moderated by Mark Han, JD. - President and Chief Legal Officer at IntuitiveX

Whether you’re a physician with an idea, a researcher exploring commercialization or a founder building in spine, bring your questions.

IntuitiveX is proud to be the Title Sponsor of Spine Venture Village at NASS 2026.

📆 Wednesday, October 14, 2026 | 1:00–2:00 PM CDT
📍Spine Venture Village, Booth #1405 | Henry B. Gonzalez Convention Center

How do you raise the capital your company needs while protecting the vision that started it?Join IntuitiveX at 2026 for...
10/03/2026

How do you raise the capital your company needs while protecting the vision that started it?

Join IntuitiveX at 2026 for “Raising Capital Without Losing Control,” a conversation about funding a company and understanding what comes with the investment.

Hear perspectives from founders and investors on funding structures, equity, and the decisions that shape a company’s future. Explore the trade-offs of bringing in capital and what it means to find investors who support your long-term direction.

Meet the panel:

Alyssa Huffman, MBA - Founder and CEO at ALLUMIN8
Andy Choi, MBA - CEO at Amplify Surgical, Inc.
Raymond Cloutier - Founder at NovApproach Spine

Moderated by Simon Robinson - Chief IP Officer and Co-Founder at IntuitiveX

Whether you’re preparing for your first raise or weighing your next round of funding, bring your questions.

IntuitiveX is proud to be the Title Sponsor of Spine Venture Village at NASS 2026.

📅 Thursday, October 15, 2026 | 9:00–10:00 AM CDT
📍 Spine Venture Village, Booth #1405 | Henry B. Gonzalez Convention Center

What does a career beyond clinical practice actually look like—and what does it take to bring a medical device to market...
10/02/2026

What does a career beyond clinical practice actually look like—and what does it take to bring a medical device to market?

Join IntuitiveX at NASS 2026 for “Going to the ‘Dark Side’: From Surgeon to Startup Leader,” a candid conversation with physicians who have made the move into industry.

Hear from physicians across spine care who have transitioned from clinical practice into leadership roles with startups. Learn what motivated the move, the challenges they faced and how physicians can shape the future of innovation from the industry side.

Meet the panel:

Ray Baker, MD
Carlton Reckling, MD
Adam Wollowick, MD, MBA

Moderated by Jeffrey Roh, MD, MBA, MSc.

Whether you’re considering a career transition or curious about what happens inside a medical device company, bring your questions.

IntuitiveX is proud to be the Title Sponsor of Spine Venture Village at NASS 2026.



📅 Thursday, October 15, 2026 | 1:00–2:00 PM CDT
📍 Spine Venture Village | Henry B. Gonzalez Convention Center

IntuitiveX is thrilled to announce that we are the Title Sponsor of the Spine Venture Village at North American Spine So...
09/25/2026

IntuitiveX is thrilled to announce that we are the Title Sponsor of the Spine Venture Village at North American Spine Society (NASS) !

Bringing new medical technologies from the lab or operating room to market takes more than just a great idea requires the right network, capital, and ex*****on strategy.

As Title Sponsor, IntuitiveX is helping create a dedicated hub within the NASS Technical Exhibition where emerging early-stage companies in robotics, diagnostics, imaging, and digital health can connect directly with leading spine surgeons, investors, and strategic partners.

We have an incredible lineup of live panel discussions and fast-pitch competitions scheduled across all 4 days in San Antonio, Texas.

If you are attending NASS this year, make sure to visit the Spine Venture Village to meet our team and see some of the emerging technologies shaping spine care.

Learn more about our involvement and see the full schedule here: https://intuitivex-spine-venture-village-2026.nnaplong.chatgpt.site/

📍 Spine Venture Village | Henry B. Gonzalez Convention Center
📅 October 14–17, 2026 | San Antonio, TX

IX Innovation, a medical IP creation and monetization company and portfolio company of IntuitiveX, in partnership with i...
02/13/2024

IX Innovation, a medical IP creation and monetization company and portfolio company of IntuitiveX, in partnership with ipCapital Group, is thrilled to announce the grant of a landmark patent for a voice-controlled medical copilot designed to revolutionize surgical procedures. The U.S. Patent and Trademark Office (USPTO) issued U.S. Patent 11,896,324 entitled “System for transcribing and performing analysis on patient data". This innovative technology, the brainchild of a team led by Dr. Jeffrey Roh, CEO of IntuitiveX, Dr. Justin Esterberg, an orthopedic surgery specialist, and John Cronin, Chairman and CEO of ipCapital Group, marks a new era in medical procedures that leverages AI/ML to provide patient-specific analysis, diagnosis and surgical control.

This pioneering technology incorporates voice command capabilities into robotic surgical systems, offering surgeons enhanced precision and efficiency. This innovation is set to redefine surgical methodologies and patient care, marking a critical milestone in IX Innovation's commitment to revolutionizing medical technology.

Under the guidance of Dr. Roh, a renowned figure in medical innovation, and Dr. Esterberg, with his profound expertise in orthopedic surgery, alongside Mr. Cronin, a pioneer in intellectual property strategy, this patent exemplifies IX Innovation's dedication to evolving medical practices through innovative solutions.

The medical copilot patent embodies a new era in surgical procedures, promising significant impact on the medical industry by broadening the capabilities of robotic surgery and elevating the standards of patient treatment.
IX Innovation, together with ipCapital, continues to lead the charge in healthcare innovation, developing technologies that not only improve patient outcomes but also transform medical practices.

For more information, please contact:
Simon Robinson – [email protected]

A link to preview the issued U.S. Patent 11,896,324:
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11896324

Integritics is dedicated to advancing Data Integrity in the industry and strives to create optimized solutions for its c...
10/14/2023

Integritics is dedicated to advancing Data Integrity in the industry and strives to create optimized solutions for its customers. The company specializes in GXP technologies, ranging from microbial IT services to quality assurance systems. They stay updated with international regulatory requirements and standards to align their services with their clients' global GMP goals. Their passion for forward-thinking drives them to fulfill societal needs and contribute to a more livable society. Personal and professional growth is their priority while offering various perks to their employees, including travel expenses for overseas trips, transportation coverage for overtime work, and support for education and personal milestones. Their product, Microbe Vestige, simplifies data management, user access control, and digital data integrity. It streamlines data organization, offers convenient report creation, and supports optimal reporting in minimal time. Users can easily implement essential validation and have access to robust user access control, in compliance with FDA regulations.

Additionally, it's worth noting that Integritics has received substantial financial support, including $300,000 in seed investment and $527,000 in funding from the Korean Government*. This funding underscores their commitment to innovation and their potential for making a significant impact in the industry.

They are in search of a senior advisor to facilitate connections with potential customers as part of their team formation in the US. In terms of their US sales strategy, they are focusing on a LinkedIn sales approach, with a particular emphasis on the "Hook" method. Additionally, they are preparing for Series A, B, C, and D funding rounds as part of their investor relations and storytelling efforts. To streamline their operations, they are seeking assistance with visa processing, corporate establishment, and bank account setup. Lastly, Integritics emphasizes attention to detail in post-US Expo activities, including contract preparation, meetings, and ensuring the integrity of Non-Disclosure Agreements (NDAs).

SCSm stands for Standard Cooling System. SCSm provides A.I. thermal management system (TMS) design/ proto-typing/ test/ ...
10/13/2023

SCSm stands for Standard Cooling System. SCSm provides A.I. thermal management system (TMS) design/ proto-typing/ test/ system analysis and product certifications. SCSm also specializes in customized system requests for TMS.

The company has developed heat-pump technology for industry eletrification. Their goal is to deliver energy management value with high quality products. This technology applies both to 75kW fuel cell stack cooling systems and 100kW cell stack Oxygen Air compressor for higher efficiency fuel cell generation.

SCSm is currently seeking an industry partnerships in the US. as well as international investments

Proxi Healthcare Company, a dynamic biotech startup founded in 2019, is dedicated to developing state-of-the-art technol...
10/12/2023

Proxi Healthcare Company, a dynamic biotech startup founded in 2019, is dedicated to developing state-of-the-art technology to shield our lives from the concealed threat of biofilm. Since 2008, their unwavering commitment to pioneering research has revolved around the effectiveness of their groundbreaking TROMATZWAVE® technology. Under the visionary leadership of their Founder & CEO, Dr. YoungWook Kim, they've substantially expanded their innovation spectrum, amassing an impressive portfolio of 122 intellectual properties spanning healthcare, automotive, and maritime domains. These inventions encompass a diverse range of patents, including oral care products, medical devices for rhinitis/sinusitis and wound therapy, air filtration systems for automotive HVACs, and biofouling solutions for ship hulls.

They are seeking guidance for marketing their innovations in the U.S. Aim to connect with 3-5 distributors for their products. Hope to share their story with potential investors and U.S. dentists for feedback. Plan to establish an R&D strategy with medical professionals, and are preparing to launch their maritime business while welcoming insights and partnerships in this endeavor.

Aston Sci., a clinical stage biopharmaceutical company that is currently focusing on clinical development of innovative ...
10/12/2023

Aston Sci., a clinical stage biopharmaceutical company that is currently focusing on clinical development of innovative medicines in oncology, immunology, and geriatrics, including therapeutic cancer vaccines. Aston Sci. is constantly listening to the changing needs of the patients and will continue to move forward to improve the lives of patients who suffer from cancer recurrence, metastasis, or side effects during cancer treatment.

Aston Sci is currently seeking international investments to support their forthcoming IPO, with a potential partnership with Frazier Investments in consideration. They have plans to establish a U.S. operational base in the near future, potentially through a merger with Epithany. They are diligently ensuring the strength of their intellectual property (IP) portfolio and are open to exploring opportunities for IP licensing from Epithany. Furthermore, they are enthusiastic about expanding their global collaboration efforts to advance their innovative medicines in oncology, immunology, and geriatrics, with a steadfast commitment to improving the lives of cancer patients worldwide.

Address

Seattle, WA

Website

,

Alerts

Be the first to know and let us send you an email when IntuitiveX posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to IntuitiveX:

Shortcuts

Share

Category